ARCHIVES

Cancer Advocates Use Benefit Analysis To Press For Funds

This article is from The Cancer Letter archive.

Vol. 16 No. 19 | May 11, 1990

Download PDF Visit The Full Archive

Related Articles

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved

November 29, 1985